Powder for Inhalation Market Size Report 2025
On Oct 29, the latest report "Global Powder for Inhalation Market 2025 by Manufacturers, Regions, Types and Applications, Forecast to 2031" from Global Info Research provides a detailed and comprehensive analysis of the global Powder for Inhalation market. The report provides both quantitative and qualitative analysis by manufacturers, regions and countries, types and applications. As the market is constantly changing, this report explores market competition, supply and demand trends, and key factors that are causing many market demand changes. The report also provides company profiles and product examples of some of the competitors, as well as market share estimates for some of the leading players in 2025.
Get Report Sample with Industry Insights https://www.globalinforesearch.com/reports/2953202/powder-for-inhalation
According to our (Global Info Research) latest study, the global Powder for Inhalation market size was valued at US$ 14066 million in 2024 and is forecast to a readjusted size of USD 19048 million by 2031 with a CAGR of 4.5% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Powder for inhalation (used in dry powder inhalers, DPIs) delivers active pharmaceutical ingredients as respirable powders driven by patient inhalation and is widely used for local treatment of respiratory diseases (asthma, COPD) and selected systemic applications (e.g., inhaled insulin). Key technical challenges are particle-size distribution, powder flow/dispersibility, physical stability and device–formulation compatibility (capsule-based, blister, or multi-dose devices); common manufacturing technologies include spray-drying, spray-freeze-drying and particle-engineering approaches to achieve the required aerosol performance. Upstream inputs include inhalation-grade APIs (with tight impurity/residual-solvent specs) and lung-safe excipients — lactose remains the predominant carrier in many commercial formulations — and many projects outsource formulation development and scale-up to specialized CDMOs.
In 2024, the global market average price for Powder for Inhalation was USD 26.7 per unit, with a total sales volume of 512 million units.
This report is a detailed and comprehensive analysis for global Powder for Inhalation market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approval.
Powder for Inhalation market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type: Tiotropium Bromide、 Salbutamol Sulfate、 Beclomethasone Dipropionate、 Others
Market segment by Application: Asthma、 COPD、 Others
Major players covered: GSK、 Novartis、 AstraZeneca、 Chiesi Farmaceutici、 Teva Pharmaceutical、 Sumitomo Pharma、 Cipla、 Glenmark Pharmaceuticals、 Orion Corporation、 Bausch Health、 Viatris、 Zhejiang Xianjun Pharmaceutical、 Shanghai Pharmaceuticals、 Chia Tai Tianqing Pharmaceutical
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Powder for Inhalation product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Powder for Inhalation, with price, sales quantity, revenue, and global market share of Powder for Inhalation from 2020 to 2025.
Chapter 3, the Powder for Inhalation competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Powder for Inhalation breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment Powder for Inhalation the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the Powder for Inhalation sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2024.and Powder for Inhalation market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Powder for Inhalation.
Chapter 14 and 15, to describe Powder for Inhalation sales channel, distributors, customers, research findings and conclusion.
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Powder for Inhalation
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
Global Info Research is a company that digs deep into global industry information to support enterprises with market strategies and in-depth market development analysis reports. We provides market information consulting services in the global region to support enterprise strategic planning and official information reporting, and focuses on customized research, management consulting, IPO consulting, industry chain research, database and top industry services. At the same time, Global Info Research is also a report publisher, a customer and an interest-based suppliers, and is trusted by more than 30,000 companies around the world. We will always carry out all aspects of our business with excellent expertise and experience.
Contact Us:
Global Info Research
Web: https://www.globalinforesearch.com
Email: report@globalinforesearch.com
CN: 0086-176 6505 2062
HK: 00852-58030175
Get Report Sample with Industry Insights https://www.globalinforesearch.com/reports/2953202/powder-for-inhalation
According to our (Global Info Research) latest study, the global Powder for Inhalation market size was valued at US$ 14066 million in 2024 and is forecast to a readjusted size of USD 19048 million by 2031 with a CAGR of 4.5% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Powder for inhalation (used in dry powder inhalers, DPIs) delivers active pharmaceutical ingredients as respirable powders driven by patient inhalation and is widely used for local treatment of respiratory diseases (asthma, COPD) and selected systemic applications (e.g., inhaled insulin). Key technical challenges are particle-size distribution, powder flow/dispersibility, physical stability and device–formulation compatibility (capsule-based, blister, or multi-dose devices); common manufacturing technologies include spray-drying, spray-freeze-drying and particle-engineering approaches to achieve the required aerosol performance. Upstream inputs include inhalation-grade APIs (with tight impurity/residual-solvent specs) and lung-safe excipients — lactose remains the predominant carrier in many commercial formulations — and many projects outsource formulation development and scale-up to specialized CDMOs.
In 2024, the global market average price for Powder for Inhalation was USD 26.7 per unit, with a total sales volume of 512 million units.
This report is a detailed and comprehensive analysis for global Powder for Inhalation market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approval.
Powder for Inhalation market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type: Tiotropium Bromide、 Salbutamol Sulfate、 Beclomethasone Dipropionate、 Others
Market segment by Application: Asthma、 COPD、 Others
Major players covered: GSK、 Novartis、 AstraZeneca、 Chiesi Farmaceutici、 Teva Pharmaceutical、 Sumitomo Pharma、 Cipla、 Glenmark Pharmaceuticals、 Orion Corporation、 Bausch Health、 Viatris、 Zhejiang Xianjun Pharmaceutical、 Shanghai Pharmaceuticals、 Chia Tai Tianqing Pharmaceutical
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Powder for Inhalation product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Powder for Inhalation, with price, sales quantity, revenue, and global market share of Powder for Inhalation from 2020 to 2025.
Chapter 3, the Powder for Inhalation competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Powder for Inhalation breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment Powder for Inhalation the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the Powder for Inhalation sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2024.and Powder for Inhalation market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Powder for Inhalation.
Chapter 14 and 15, to describe Powder for Inhalation sales channel, distributors, customers, research findings and conclusion.
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Powder for Inhalation
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
Global Info Research is a company that digs deep into global industry information to support enterprises with market strategies and in-depth market development analysis reports. We provides market information consulting services in the global region to support enterprise strategic planning and official information reporting, and focuses on customized research, management consulting, IPO consulting, industry chain research, database and top industry services. At the same time, Global Info Research is also a report publisher, a customer and an interest-based suppliers, and is trusted by more than 30,000 companies around the world. We will always carry out all aspects of our business with excellent expertise and experience.
Contact Us:
Global Info Research
Web: https://www.globalinforesearch.com
Email: report@globalinforesearch.com
CN: 0086-176 6505 2062
HK: 00852-58030175
